These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 15747248)

  • 21. Characterization of mumps virus strains with varying neurovirulence.
    Rafiefard F; Johansson B; Tecle T; Orvell C
    Scand J Infect Dis; 2005; 37(5):330-7. PubMed ID: 16051568
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of a neonatal rat model for prediction of mumps virus neurovirulence in humans.
    Rubin SA; Pletnikov M; Taffs R; Snoy PJ; Kobasa D; Brown EG; Wright KE; Carbone KM
    J Virol; 2000 Jun; 74(11):5382-4. PubMed ID: 10799619
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neurovirulence.
    Wood D
    Dev Biol Stand; 1999; 101():127-9. PubMed ID: 10566785
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development and biological properties of a new live attenuated mumps vaccine.
    Saika S; Kidokoro M; Kubonoya H; Ito K; Ohkawa T; Aoki A; Nagata N; Suzuki K
    Comp Immunol Microbiol Infect Dis; 2006; 29(2-3):89-99. PubMed ID: 16647119
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mumps vaccine virus strains and aseptic meningitis.
    Bonnet MC; Dutta A; Weinberger C; Plotkin SA
    Vaccine; 2006 Nov; 24(49-50):7037-45. PubMed ID: 16884835
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Comparative evaluation of neurovirulence of domestic and foreign live mumps vaccine].
    Maksimova OA; Popov VF; Bektimirov TA; Grigor'eva LV; Iunasova TN; Kaplunova OP; Sharova OK
    Vopr Virusol; 2001; 46(5):31-5. PubMed ID: 11715706
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The F gene of rodent brain-adapted mumps virus is a major determinant of neurovirulence.
    Lemon K; Rima BK; McQuaid S; Allen IV; Duprex WP
    J Virol; 2007 Aug; 81(15):8293-302. PubMed ID: 17475640
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gene-specific contributions to mumps virus neurovirulence and neuroattenuation.
    Sauder CJ; Zhang CX; Ngo L; Werner K; Lemon K; Duprex WP; Malik T; Carbone K; Rubin SA
    J Virol; 2011 Jul; 85(14):7059-69. PubMed ID: 21543475
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Borna disease virus (BDV)-induced model of autism: application to vaccine safety test design.
    Carbone KM; Rubin SA; Pletnikov M
    Mol Psychiatry; 2002; 7 Suppl 2():S36-7. PubMed ID: 12142944
    [No Abstract]   [Full Text] [Related]  

  • 30. Molecular biology, pathogenesis and pathology of mumps virus.
    Rubin S; Eckhaus M; Rennick LJ; Bamford CG; Duprex WP
    J Pathol; 2015 Jan; 235(2):242-52. PubMed ID: 25229387
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The molecular epidemiology of mumps virus.
    Mühlemann K
    Infect Genet Evol; 2004 Sep; 4(3):215-9. PubMed ID: 15450201
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Genetic markers of the mumps virus].
    Winterhalter-Matas A
    Lijec Vjesn; 1990; 112(1-2):13-6. PubMed ID: 1694947
    [TBL] [Abstract][Full Text] [Related]  

  • 33. On the morphological evaluation of the neurovirulence safety of attenuated mumps virus strains in monkeys.
    Levenbuk IS; Nikolayeva MA; Chigirinsky AE; Ralf NM; Kozlov VG; Vardanyan NV; Sliopushkina VG; Kolomiets OL; Rukhamina ML; Grigoryeva LV
    J Biol Stand; 1979 Jan; 7(1):9-19. PubMed ID: 114528
    [No Abstract]   [Full Text] [Related]  

  • 34. Pathogenicity of mumps virus in the marmoset.
    Saika S; Kidokoro M; Ohkawa T; Aoki A; Suzuki K
    J Med Virol; 2002 Jan; 66(1):115-22. PubMed ID: 11748667
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Accumulation of defective interfering viral particles in only a few passages in Vero cells attenuates mumps virus neurovirulence.
    Šantak M; Markušić M; Balija ML; Kopač SK; Jug R; Örvell C; Tomac J; Forčić D
    Microbes Infect; 2015 Mar; 17(3):228-36. PubMed ID: 25479555
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Adverse effects following vaccinations and effectiveness of different live vaccines against mumps].
    Magdzik W; Zieliński A
    Przegl Epidemiol; 2002; 56(3):377-89. PubMed ID: 12608087
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Potency estimation of measles, mumps and rubella trivalent vaccines with quantitative PCR infectivity assay.
    Schalk JA; de Vries CG; Jongen PM
    Biologicals; 2005 Jun; 33(2):71-9. PubMed ID: 15939284
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mumps outbreaks in Canada and the United States: time for new thinking on mumps vaccines.
    Peltola H; Kulkarni PS; Kapre SV; Paunio M; Jadhav SS; Dhere RM
    Clin Infect Dis; 2007 Aug; 45(4):459-66. PubMed ID: 17638194
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A single nucleotide change in the mumps virus F gene affects virus fusogenicity in vitro and virulence in vivo.
    Malik T; Sauder C; Wolbert C; Zhang C; Carbone KM; Rubin S
    J Neurovirol; 2007 Dec; 13(6):513-21. PubMed ID: 18097883
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mumps virus vaccine.
    Bock LL
    Pediatrics; 1969 May; 43(5):907. PubMed ID: 5769521
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.